GLP-1 medications have become an important option in medically supervised weight management because they can influence appetite, food intake, and other processes involved in weight regulation. Medications in this category include GLP-1 receptor agonists such as semaglutide, while tirzepatide activates both GLP-1 and GIP receptors. When clinically appropriate, AM Rx may prescribe medications such as Wegovy, Zepbound, Ozempic, or Mounjaro as part of an individualized weight-loss plan.
Medical weight loss is about more than taking medication. A provider evaluates your health history, current medications, treatment goals, and eligibility before recommending an approach. AM Rx combines medical evaluation with coaching, nutrition and fitness guidance, and ongoing support for eligible members. This can help make medication one part of a broader plan focused on sustainable weight management.
How GLP-1 Medications Affect Appetite
GLP-1 is a naturally occurring hormone involved in appetite regulation and calorie intake. GLP-1 receptor agonists work by activating these receptors, which can influence hunger and food intake. Semaglutide, the active ingredient in medications including Wegovy and Ozempic, acts as a GLP-1 receptor agonist and can reduce calorie intake, with its weight effects thought to be largely related to appetite.
Because appetite can decrease, some people may find it easier to follow a reduced-calorie eating pattern. You may feel satisfied with smaller portions or experience fewer cravings during treatment. However, the response is different for each person, and medication should not be viewed as a reason to skip meals or avoid getting adequate nutrition.
Tirzepatide Works on Two Hormone Pathways
Some medications used in medical weight management work differently from traditional GLP-1-only treatments. Tirzepatide, for example, activates both GIP and GLP-1 receptors. These hormone pathways are involved in appetite regulation, food intake, and blood sugar control.
Zepbound is the FDA-approved tirzepatide product for chronic weight management in eligible adults. The FDA states that Zepbound activates GIP and GLP-1 hormone receptors to reduce appetite and food intake and is used alongside a reduced-calorie diet and increased physical activity.
GLP-1 Medications May Help With Portion Control
When appetite and fullness change, some people find that their usual portions become more than they need. This can make it easier to eat smaller meals without feeling that they are constantly fighting hunger.
The goal is not simply to eat as little as possible. A healthy medical weight-loss plan should still provide enough protein, fiber, vitamins, minerals, and fluids. Nutrition guidance can help you choose foods that provide good nutritional value even when your appetite is lower.
They Can Slow Gastric Emptying
Some GLP-1 medications can delay gastric emptying, meaning food moves from the stomach into the small intestine more slowly. This effect can contribute to changes in fullness and appetite. Semaglutide’s FDA labeling, for example, notes that it delays gastric emptying.
Tirzepatide also delays gastric emptying, although the effect is greatest after the first dose and diminishes over time. This is one reason digestive symptoms can occur when treatment begins or when doses are increased. Patients should follow their provider’s instructions and report significant or persistent symptoms.
Medical Evaluation Comes First
GLP-1 medications are prescription treatments and are not appropriate for everyone. Before recommending medication, a healthcare provider needs to consider factors such as medical history, current medications, health conditions, and individual treatment goals.
AM Rx begins its weight-loss process with an online consultation and provider evaluation. If a GLP-1 medication is clinically appropriate, a licensed provider may prescribe it. Medication is not guaranteed, and treatment decisions are based on individual medical needs and professional judgment.
Medication Works Alongside Lifestyle Changes
GLP-1 medications are generally used as part of a broader weight-management approach rather than as a replacement for healthy habits. The FDA’s approval of Zepbound for chronic weight management specifically includes its use alongside a reduced-calorie diet and increased physical activity.
Nutrition and exercise can also help support long-term progress. Building realistic habits around meals, movement, sleep, and hydration can make a weight-management plan more sustainable. AM Rx includes coaching along with nutrition and fitness guidance for eligible members, providing support beyond the prescription itself.
Results Can Vary From Person to Person
There is no single amount of weight that everyone should expect to lose with a GLP-1 medication. Clinical trial results represent averages across groups of participants, while individual outcomes can depend on many factors.
Your starting weight, medical history, medication response, treatment adherence, nutrition, physical activity, and other health factors can all influence your results. AM Rx also emphasizes that results vary and that weight loss is not guaranteed.
Side Effects Are Possible
Like other prescription medications, GLP-1 treatments can cause side effects. Gastrointestinal symptoms are common with several medications in this category and may include nausea, vomiting, diarrhea, constipation, or abdominal discomfort.
The experience can differ depending on the medication and individual patient. If you experience concerning or persistent symptoms, contact your healthcare provider. AM Rx encourages members to record side effects through its patient portal so the care team can monitor the response and determine whether treatment adjustments are appropriate.
Dose Changes Are Usually Gradual
Many GLP-1 medications are introduced at a lower dose before gradually increasing to a maintenance dose. This approach can help the body adjust and may reduce the likelihood of certain side effects.
The appropriate dose depends on the medication and the individual treatment plan. Patients should never increase their dose simply because they want faster results. A licensed healthcare provider should determine when a dose change is appropriate.
Ongoing Monitoring Can Improve Treatment
Medical weight loss does not end when a prescription is issued. Continued monitoring can help providers understand how well a medication is working and whether side effects or other concerns need attention.
AM Rx provides ongoing communication with its care team, including secure messaging and provider follow-ups for eligible members. Its team can also track progress and adjust the treatment plan when appropriate.
How AM Rx Supports Medical Weight Loss
AM Rx brings medical evaluation and lifestyle support together through its online weight-loss program. Eligible members can complete an online consultation, receive a provider evaluation, and potentially receive a prescription if medication is clinically appropriate.
The program also includes access to a dedicated coach, nutrition and fitness guidance, and ongoing communication. If a prescribed GLP-1 medication requires insurance approval, AM Rx’s care coordination team can help eligible members explore coverage and prior authorization options.
Final Thoughts
GLP-1 medications can support medical weight loss by influencing appetite, food intake, fullness, and other metabolic processes. Medications such as semaglutide activate GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors. These effects can make it easier for some people to follow a reduced-calorie eating pattern when combined with appropriate lifestyle changes.
For eligible patients, AM Rx combines provider evaluation with medication options, coaching, nutrition, fitness guidance, and ongoing support. Since results and side effects vary, treatment should be supervised by a qualified healthcare professional who can determine whether a GLP-1 medication is appropriate and monitor progress throughout the weight-management journey.
